Jun 23, 2011
Santa Monica, Calif., June 23, 2011 /PRNewswire/ -- Derycz Scientific, Inc. (OTC BB: DYSC) today announced that wholly-owned subsidiary Reprints Desk Inc. had signed distribution agreements for biomedical, healthcare, and clinical medicine PDF content from publishers The Journal of Rheumatology and Landes Bioscience. Agreements with these prominent publishers enhance the dissemination of important scientific information, and expand the growing list of journals that Reprints Desk can access quickly in order to facilitate fast turnaround time on single article document delivery orders placed by researchers at leading Life Science companies.
"Reprints Desk customers rely on us to provide articles quickly and in a copyright-compliant manner," said Derycz Scientific's Head of Publisher Relations Jan Peterson. "Improving our electronic sourcing capabilities helps us to deliver these benefits to customers and to realize competitive advantages in our business in areas such as document delivery speed and quality, while providing publishers with a channel into research intensive companies."
The Journal of Rheumatology is a monthly international serial edited by Duncan A. Gordon, featuring research articles on clinical subjects from scientists working in rheumatology and related fields. Landes Bioscience is a Texas-based publisher of biomedicine journals, primary books, and medical reference manuals. Its journal Cell Cycle earned the highest percent increase in total citations in molecular biology and genetics for the period of July 2007 to August 2007, during which 1490 papers were cited 6228 times.
Derycz Scientific, Inc. develops companies, products, services and systems that facilitate the re-use of published content in a manner that helps organizations achieve their marketing, communication and research goals effectively and in compliance with copyright law and regulatory rules. Its subsidiary companies include Reprints Desk, Inc., Pools Press, Inc. and the newly acquired Techniques Appliquees aux Arts Graphiques, S.p.A. (TAAG).
About Derycz Scientific®
Derycz Scientific, Inc. develops companies, products, services and systems that facilitate the re-use of published content in a manner that helps organizations achieve their marketing, communication and research goals effectively and in compliance with copyright law and regulatory rules. Its subsidiary companies include Reprints Desk, Inc., Pools Press, Inc. and the newly acquired Techniques Appliquees aux Arts Graphiques, S.p.A. (TAAG). Reprints Desk offers a one-stop solution for reprints, ePrints and single articles, and has delivered millions of articles worldwide. Reprints Desk is an innovator in content retrieval and ePrint delivery, with services designed to help make effective use of published articles in a copyright-compliant manner. Pools Press has excelled in the reprint market for more than 30 years. It provides professionally printed articles from medical and technical journals; prints booklets, catalogs, pamphlets, direct mail pieces and newsletters; and works with publishers who wish to outsource a portion of or all of their reprints business. TAAG offers printing, distribution and information logistics services, with core competencies in the professional production and distribution of clinical trial kits and clinical article reprints for the life sciences industry. For more information, please visit www.deryczscientific.com.
About Reprints Desk
Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions and scientific, technical, and medical (STM) research. Organizations based on intellectual property (IP) choose Reprints Desk because of its collaborative business approach, efficient article supply system and services, and commitment to quality post-sales support. Outsell Inc., an independent analyst and advisory firm, ranked Reprints Desk #1 in the most recent Document Delivery Vendor Scorecard.
Certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company's success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the Company's Annual Report on Form 10-K. The Company assumes no obligation to update the cautionary information in this release.
SOURCE Derycz Scientific, Inc.